RespireRx Pharmaceuticals Inc (fka RSPI)

[neuroinv]

When you develop a sober and balanced perspective, post something to show it.

The discussion on this Board has been deteriorating. With a few exceptions, there is far too much kvetching and complaining, like a bunch of caffeinated housewives with too much time on their hands. There is plenty of genuine uncertainty, which is addressed on intermittent occasion: Is the RD indication for real, with real potential value? Is the trial design one which is likely to work, and if it doesn't, what then? To what degree are Ampakines as a class viewed negatively by the FDA--or not? What will Schering-Plough do? What are the industry trends for partnerships and indications, and what do they augur for Cortex, if anything? How much clout does R&R have in trying to force a sale on the cheap?

Those are just a few examples. Substantive interchange could have been had, and I am not talking about rosy spin--in fact, it is ironic that Gfp, who self-righteously complains that I spin, has been at times a most promiscuous "slam dunk" pollyanna. Yowling that management must buy 'millions' of dollars of stock to be taken seriously, or hyping a Lilly abstract that, if read with any care, deserves attention but not adulation; or paranoid blather about "scams"--that kind of claptrap is a waste of time, time I am disinclined to give.

NeuroInvestment